Displaying 13 - 24 of 41
Metabolism, Alcohol & Toxicity

Focusing on metabolic risk of MASLD. EXCEL study design and major outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Integrating MASLD/MASH-Specific Therapy into Guideline-Aligned Real-World Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence (Complete Sess...

Webcasts
View
Metabolism, Alcohol & Toxicity

MASLD – current treatment  strategies  - from metabolic indices to patient reported outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IPSEN: Holistic care in PBC: Achieving biochemical response and symptom relief (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: Providing Better Care in PBC as a Patient-Based Clinician

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: Providing Better Care in PBC as a Patient-Based Clinician

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Personalised management of MASH (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC in practice (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC (Complete Session)

Webcasts
View
Displaying 13 - 24 of 41